INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2014

Vitamin D3 supplementation reduced all-cause mortality in randomized trials of adults.

Across 56 randomized trials with 95,286 participants, supplemental vitamin D decreased all-cause mortality (RR 0.97; 95% CI 0.94 to 0.99; P = 0.02). When examined by specific compound, only cholecalciferol yielded a significant reduction in mortality (RR 0.94; 95% CI 0.91 to 0.98; 38 trials), whereas ergocalciferol and active forms showed no significant mortality benefit. Vitamin D3 also lowered cancer mortality (RR 0.88; 95% CI 0.78 to 0.98), but combined use with calcium raised nephrolithiasis risk.

Study type
Systematic review and meta-analysis of randomized trials
Who was studied
95,286 adults across 56 randomized clinical trials
What was measured
All-cause mortality, cancer mortality, nephrolithiasis, and hypercalcemia

THE PAPER

Vitamin D supplementation for prevention of mortality in adults.

Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C. Cochrane Database Syst Rev, 2014.

PubMed 24414552 ↗DOI 10.1002/14651858.CD007470.pub3 ↗

CancerNutrients & adequacyKidney healthHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.